These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36649220)

  • 21. Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulence.
    Epp E; Vanier G; Harcus D; Lee AY; Jansen G; Hallett M; Sheppard DC; Thomas DY; Munro CA; Mullick A; Whiteway M
    PLoS Pathog; 2010 Feb; 6(2):e1000753. PubMed ID: 20140196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia.
    Rosenberg A; Ene IV; Bibi M; Zakin S; Segal ES; Ziv N; Dahan AM; Colombo AL; Bennett RJ; Berman J
    Nat Commun; 2018 Jun; 9(1):2470. PubMed ID: 29941885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluconazole susceptibility and genotypic heterogeneity of oral Candida albicans colonies from the patients with cancer receiving chemotherapy in China.
    Sun J; Qi C; Lafleur MD; Qi QG
    Int J Oral Sci; 2009 Sep; 1(3):156-62. PubMed ID: 20695081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competitive Fitness of Fluconazole-Resistant Clinical Candida albicans Strains.
    Popp C; Hampe IAI; Hertlein T; Ohlsen K; Rogers PD; Morschhäuser J
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of drug resistance in experimental populations of Candida albicans.
    Cowen LE; Sanglard D; Calabrese D; Sirjusingh C; Anderson JB; Kohn LM
    J Bacteriol; 2000 Mar; 182(6):1515-22. PubMed ID: 10692355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of ERG11 Overexpression in Candida albicans isolates from environmental sources and clinical isolates treated with inhibitory and subinhibitory concentrations of fluconazole.
    Morais Vasconcelos Oliveira J; Conceição Oliver J; Latércia Tranches Dias A; Barbosa Padovan AC; Siqueira Caixeta E; Caixeta Franco Ariosa M
    Mycoses; 2021 Feb; 64(2):220-227. PubMed ID: 33176021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of ethanol tolerant strains of Candida albicans by repeated ethanol exposure results in strains with reduced susceptibility to fluconazole.
    Day AW; Kumamoto CA
    PLoS One; 2024; 19(2):e0298724. PubMed ID: 38377103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans].
    Zhang X; Liu ZH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):279-84. PubMed ID: 27116986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing.
    Wang H; Kong F; Sorrell TC; Wang B; McNicholas P; Pantarat N; Ellis D; Xiao M; Widmer F; Chen SC
    BMC Microbiol; 2009 Aug; 9():167. PubMed ID: 19682357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance Surveillance in Candida albicans: A Five-Year Antifungal Susceptibility Evaluation in a Brazilian University Hospital.
    Peron IH; Reichert-Lima F; Busso-Lopes AF; Nagasako CK; Lyra L; Moretti ML; Schreiber AZ
    PLoS One; 2016; 11(7):e0158126. PubMed ID: 27414653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genetic basis of fluconazole resistance development in Candida albicans.
    Morschhäuser J
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):240-8. PubMed ID: 12084466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aneuploidy Enables Cross-Adaptation to Unrelated Drugs.
    Yang F; Teoh F; Tan ASM; Cao Y; Pavelka N; Berman J
    Mol Biol Evol; 2019 Aug; 36(8):1768-1782. PubMed ID: 31028698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expandable and reversible copy number amplification drives rapid adaptation to antifungal drugs.
    Todd RT; Selmecki A
    Elife; 2020 Jul; 9():. PubMed ID: 32687060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal effect of Echinophora platyloba on expression of CDR1 and CDR2 genes in fluconazole-resistant Candida albicans.
    Khajeh E; Hosseini Shokouh SJ; Rajabibazl M; Roudbary M; Rafiei S; Aslani P; Farahnejad Z
    Br J Biomed Sci; 2016; 73(1):44-8. PubMed ID: 27182677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic in vitro activity of sodium houttuyfonate with fluconazole against clinical Candida albicans strains under planktonic growing conditions.
    Shao J; Cui Y; Zhang M; Wang T; Wu D; Wang C
    Pharm Biol; 2017 Dec; 55(1):355-359. PubMed ID: 27931143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing Susceptibility of Drug-Resistant
    Sharafutdinov IS; Ozhegov GD; Sabirova AE; Novikova VV; Lisovskaya SA; Khabibrakhmanova AM; Kurbangalieva AR; Bogachev MI; Kayumov AR
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32024254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
    Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
    Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.